Welcome to our dedicated page for VEECO INSTRUMENTS SEC filings (Ticker: VECO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Veeco Instruments Inc. filings document the regulatory record for a semiconductor process equipment manufacturer serving advanced semiconductor fabrication and packaging applications. Form 8-K reports cover operating and financial results, earnings-release exhibits, material-event disclosures and capital-structure information.
Proxy and annual meeting filings describe Veeco's governance framework, director elections, shareholder voting matters, stock incentive plan proposals, auditor ratification and advisory executive-compensation votes. The filings also provide formal disclosure context for the company's common stock, board oversight, material agreements and risks tied to semiconductor equipment markets and customer demand.
Veeco Instruments Inc. files its annual report describing a global semiconductor equipment business focused on laser annealing, ion beam, MOCVD, CVD, lithography, wet processing, MBE and ALD tools serving four end-markets: Semiconductor, Compound Semiconductor, Data Storage, and Scientific & Other.
Veeco highlights a pending merger with Axcelis Technologies under which Veeco would become a wholly owned subsidiary after regulatory approvals, with stockholders of both companies already approving the deal. Backlog grew to $554.9 million as of December 31, 2025, up from $409.6 million a year earlier, reflecting strong order visibility in cyclical markets.
The report details extensive risk factors, including heavy exposure to non‑U.S. sales, tightening U.S.–China export controls, tariffs, supply-chain dependence on limited suppliers, rapid technology change, cybersecurity threats, and constraints and fees associated with the Axcelis merger. Veeco also notes $230.0 million of 2029 convertible notes and a $250.0 million undrawn credit facility, as well as a workforce of 1,265 employees with relatively low voluntary turnover.
Veeco Instruments reported lower results for the fourth quarter and full year 2025 but issued an outlook calling for growth in 2026. Q4 2025 revenue was $165.0 million versus $182.1 million a year earlier, with GAAP diluted EPS of $0.02 compared with $0.26. Full-year 2025 revenue was $664.3 million versus $717.3 million in 2024, and GAAP diluted EPS declined to $0.59 from $1.23; non-GAAP diluted EPS fell to $1.33 from $1.74. Management cited accelerated bookings in semiconductor, compound semiconductor and data storage markets and referenced a planned merger with Axcelis as positioning the business for AI and high-performance computing demand. For Q1 2026, Veeco guides net sales of $150–$170 million and non-GAAP diluted EPS of $0.14–$0.24, and for full-year 2026 it guides net sales of $740–$800 million with non-GAAP diluted EPS of $1.50–$1.85.
Manulife Financial Corporation and its investment subsidiaries filed an amended Schedule 13G reporting their institutional ownership of Veeco Instruments Inc. common stock as of December 31, 2025.
Manulife Investment Management (US) LLC beneficially owned 2,531,978 shares, or 4.21% of Veeco’s common stock, while Manulife Investment Management Ltd held 18,615 shares, or 0.03%. Veeco had 60,162,510 shares outstanding as of October 30, 2025. Manulife Financial Corporation itself reported no directly held shares but may be deemed to beneficially own the shares held by its subsidiaries. The filing indicates the Manulife group’s aggregate holdings are 5 percent or less of Veeco’s common stock.
Axcelis Technologies provides an update on its pending merger with Veeco, describing the deal as a transformational step to create a new leader in semiconductor capital equipment with complementary technologies and a broader market opportunity.
Integration teams across all functional and operational areas have been formed and have already held a second integration summit with more than 50 employees from both companies. Regulatory clearances have been obtained for the U.S. Hart-Scott-Rodino filing and foreign direct investment approvals in Ireland, Germany and the UK, with approval from China’s State Administration for Market Regulation still pending. Both Axcelis and Veeco stockholders approved the merger at meetings held on February 6, 2026. The message also reminds investors that a Form S-4 registration statement and a joint proxy statement/prospectus are on file with the SEC and emphasizes the risks and uncertainties typical of large mergers, including regulatory approvals, integration challenges, costs and potential impacts on relationships with customers, suppliers and employees.
Veeco Instruments Inc. reported that its stockholders approved all proposals related to the company’s pending merger with Axcelis Technologies, Inc. at a special meeting held on February 6, 2026. The merger agreement proposal received 53,408,907 votes for, 469,828 against and 10,875 abstentions, satisfying the required majority of outstanding shares.
As of the December 26, 2025 record date, 60,297,087 shares were outstanding, with 53,889,610 shares, or about 89.37% of voting power, present to constitute a quorum. Completion of the merger still requires remaining customary closing conditions, including final regulatory approval from China’s State Administration for Market Regulation, and is expected in the second half of 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G reporting their beneficial ownership of 6,077,505.67 shares of Veeco Instruments Inc. common stock, representing 10.1% of the class.
FMR LLC has sole voting power over 6,038,927.95 shares and sole dispositive power over 6,077,505.67 shares, with no shared voting or dispositive power. Abigail P. Johnson reports sole dispositive power over the same 6,077,505.67 shares. The securities are certified as acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Veeco.
Veeco Instruments Inc. received an amended Schedule 13G showing that FMR LLC and Abigail P. Johnson collectively report beneficial ownership of 5,926,996.32 shares of Veeco common stock, representing 9.8% of the class as of 12/31/2025.
FMR LLC reports sole voting power over 5,862,796.95 shares and sole dispositive power over 5,926,996.32 shares, with no shared voting or dispositive power. Abigail P. Johnson reports sole dispositive power over the same 5,926,996.32 shares and no voting power.
The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Veeco. One or more other persons may have rights to dividends or sale proceeds, but no such person holds more than five percent of the common stock.
Veeco Instruments Inc. reported progress on its planned merger with Axcelis Technologies and disclosed a customs issue that could affect 2025 results. The United Kingdom cleared the merger with a no further action letter, and Axcelis and Veeco waived a Swedish investment-screening closing condition. The final pending regulatory approval is from China’s State Administration for Market Regulation.
Separately, Veeco shipped Laser Annealing systems to China worth approximately $15 million that are being held at the Port of San Francisco for review by U.S. Customs and BIS. Because clearance is uncertain and payment has not been sought, Veeco has not recognized this revenue. If it cannot recognize the $15 million before issuing 2025 financial statements, revenue for the quarter ended December 31, 2025 would fall below its previously communicated revenue and EPS guidance ranges.
Veeco Instruments Inc. reports two Laser Annealing system shipments to China, totaling approximately $15 million in revenue, are being held at the Port of San Francisco by U.S. Customs and Border Protection and the Bureau of Industry and Security. Although title and risk of loss have passed to customers, Veeco has not recognized this revenue because it cannot yet conclude that a significant reversal is unlikely.
The company states that if the uncertainty is not resolved before issuing its financial statements for the year ended December 31, 2025, this revenue may not be recognized for that period, which would cause revenue to fall below previously communicated revenue and earnings per share guidance for the fourth quarter. Veeco also notes progress on its planned merger with Axcelis Technologies, Inc., including a no further action letter from the United Kingdom Investment Security Unit and waiver of certain Swedish screening conditions, with final Chinese regulatory approval and shareholder votes still pending.
Veeco Instruments Inc. filed a Form 8-K supplementing its definitive joint proxy statement/prospectus for the proposed merger with Axcelis Technologies, Inc., and disclosed three stockholder lawsuits challenging proxy disclosures and seeking to enjoin or rescind the Merger.
The company provided supplemental background and financial adviser analyses, including UBS discounted cash flow results showing implied Veeco per‑share ranges of $30.14 to $36.54 standalone and $32.91 to $40.07 for the combined company, and stated certain governance, compensation and equity‑award conversion mechanics. Veeco says the allegations lack merit but voluntarily supplemented disclosure to avoid delay; the Veeco special meeting is scheduled for February 6, 2026.